Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Thor Straten

Showing results (81-90 of 171) with videos related to

Pageof 18
Sort By:
Cancer Immunology, Immunotherapy : CII|October 29, 2010
Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donorsRikke Sick Andersen, Rikke Bæk Sørensen, Cathrin Ritter, et al.
The Journal of Investigative Dermatology|February 13, 2009
Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56Rikke Baek Sørensen, Mikkel Faurschou, Lone Troelsen, et al.
Stem Cell Investigation|January 13, 2017
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trialNicolai Grønne Jørgensen, Shamaila Munir Ahmad, Niels Abildgaard, et al.
Journal of Leukocyte Biology|October 18, 2024
MerTK signaling in human primary T cells modulates memory potential and improves recall responseAnne Rahbech, Annina Kurzay, Sara Fresnillo Saló, et al.
Oncoimmunology|December 25, 2012
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transferMarco Donia, Paolo Fagone, Ferdinando Nicoletti, et al.
Blood|June 29, 2011
Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-αCaroline Hasselbalch Riley, Morten Krogh Jensen, Marie Klinge Brimnes, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 2008
The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell linesRikke Baek Sørensen, Niels Junker, Alexei Kirkin, et al.
The Journal of Investigative Dermatology|September 28, 2012
Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusionMarco Donia, Morten Hansen, Sarah L Sendrup, et al.
Oncoimmunology|May 12, 2015
Spontaneous presence of FOXO3-specific T cells in cancer patientsStine Kiaer Larsen, Shamaila Munir Ahmad, Manja Idorn, et al.
Blood|September 16, 2004
Immunogenicity of Bcl-2 in patients with cancerMads Hald Andersen, Inge Marie Svane, Pia Kvistborg, et al.
Pageof 18

Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
Cancer Immunology, Immunotherapy : CII|October 29, 2010
Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donorsRikke Sick Andersen, Rikke Bæk Sørensen, Cathrin Ritter, et al.
The Journal of Investigative Dermatology|February 13, 2009
Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56Rikke Baek Sørensen, Mikkel Faurschou, Lone Troelsen, et al.
Stem Cell Investigation|January 13, 2017
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trialNicolai Grønne Jørgensen, Shamaila Munir Ahmad, Niels Abildgaard, et al.
Journal of Leukocyte Biology|October 18, 2024
MerTK signaling in human primary T cells modulates memory potential and improves recall responseAnne Rahbech, Annina Kurzay, Sara Fresnillo Saló, et al.
Oncoimmunology|December 25, 2012
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transferMarco Donia, Paolo Fagone, Ferdinando Nicoletti, et al.
Blood|June 29, 2011
Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-αCaroline Hasselbalch Riley, Morten Krogh Jensen, Marie Klinge Brimnes, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 2008
The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell linesRikke Baek Sørensen, Niels Junker, Alexei Kirkin, et al.
The Journal of Investigative Dermatology|September 28, 2012
Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusionMarco Donia, Morten Hansen, Sarah L Sendrup, et al.
Oncoimmunology|May 12, 2015
Spontaneous presence of FOXO3-specific T cells in cancer patientsStine Kiaer Larsen, Shamaila Munir Ahmad, Manja Idorn, et al.
Blood|September 16, 2004
Immunogenicity of Bcl-2 in patients with cancerMads Hald Andersen, Inge Marie Svane, Pia Kvistborg, et al.
Pageof 18